PROMICOL products

The SANYGO^® BVT1 rapid test system comes along with a proprietary point-of-care device the SANYTEC^® 10. This point-of-care device is a benchtop analyzer that analyzes the amount of light emitted during the bioluminescence reaction in a single cuvette.

The SANYGO whole blood assay provides a rapid test platform for analysis of the measurement of ATP release, which is used to identify patients who may be at risk for platelet based bleeding or thrombotic complications. The current technology in blood testing can not detect the efficacy of DOAC on the coagulation in “real-time”. At PROMICOL we are focussed on giving back certainty to high-risk patients regarding their [medical and pharmaceutical] requirements.